Interdisciplinary Research on Oral Manifestations of HIV/AIDS in Vulnerable Populations (P01)

The summary for the Interdisciplinary Research on Oral Manifestations of HIV/AIDS in Vulnerable Populations (P01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Interdisciplinary Research on Oral Manifestations of HIV/AIDS in Vulnerable Populations (P01): -Purpose. The primary goal of this funding opportunity announcement (FOA) is to drive interdisciplinary research to study the oral manifestations and complications associated with HIV/AIDS-related immunosuppression in vulnerable populations, including children and adolescents. The applicants are expected to develop highly integrated projects that comprehensively address the existing gaps in knowledge of the epidemiology, prevention and pathogenesis of the oral complications of HIV disease and that promote interventions that could reduce the burden of disease among disproportionately affected racial and ethnic minority communities. Regardless of the theme, projects in each multidisciplinary program will be expected to be synergistic and to utilize cutting-edge approaches such as genomics, proteomics, molecular imaging and other emerging technologies to achieve their goals. In addition, it is expected that these projects will provide interdisciplinary career development opportunities for investigators new to the field of oral AIDS. Applicants are encouraged to include pediatric/adolescent populations in their research. -Mechanism of Support. This FOA will use the NIH Program Project (P01) award mechanism.

Federal Grant Title:	Interdisciplinary Research on Oral Manifestations of HIV/AIDS in Vulnerable Populations (P01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-08-117
Type of Funding:	Grant
CFDA Numbers:	93.121
CFDA Descriptions:	Oral Diseases and Disorders Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Aug 13, 2010
Posted Date:	Mar 20, 2008
Creation Date:	Dec 02, 2008
Archive Date:	Dec 03, 2008
Total Program Funding:	$4,800,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Private institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) State governments Public and State controlled institutions of higher education City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses
Additional Information on Eligibility: Foreign institutions are not eligible to apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed); • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research ...; • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...; • Epidemiological and Behavioral Research in Oral Health; • Metagenomic Analyses of the Oral Microbiome; • Phase Iii Clinical Trials in Oral Infectious Diseases
More Grants from the National Institutes of Health: • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed); • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required); • Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...; • NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...; • Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...